[1] Xie JJ, Wu ZY. Wilson′s Disease in China. Neurosci Bull, 2017,33:323-330.
[2] Ferenci P, Ott P. Wilson's disease: Fatal when overlooked, curable when diagnosed. J Hepatol, 2019,71:222-224.
[3] Ferenci P. Phenotype-genotype correlations in patients with Wilson′s disease. Ann N Y Acad Sci, 2014,1315:1-5. .
[4] Usta J, Wehbeh A, Rida K, et al. Phenotype-genotype correlation in Wilson disease in a large Lebanese family: association of c.2299insC with hepatic and of p. Ala1003Thr with neurologic phenotype. PloS One, 2014,9:e109727.
[5] Li X, Feng Z, Tang W, et al. Sex Differences in Clinical Characteristics and Brain MRI Change in Patients With Wilson's Disease in a Chinese Population. Front Physiol, 2018,9:1429.
[6] Xu R, Jiang YF, Zhang YH, et al. The optimal threshold of serum ceruloplasmin in the diagnosis of Wilson′s disease: A large hospital-based study. PLoS One, 2018,13:e0190887. .
[7] Poujois A, Trocello JM, Djebrani-Oussedik N, et al. Exchan-geable copper: a reflection of the neurological severity in Wilson's disease. Eur J Neurol, 2017,24:154-160.
[8] Sini M, Sorbello O, Civolani A, et al. Non-invasive assessment of hepatic fibrosis in a series of patients with Wilson′s Disease. Dig Liver Dis, 2012,44:487-491. .
[9] Yang X, Tang XP, Zhang YH, et al. Prospective evaluation of the diagnostic accuracy of hepatic copper content, as determined using the entire core of a liver biopsy sample. Hepatology, 2015,62:1731-1741. .
[10] Weiskirchen S, Kim P, Weiskirchen R. Determination of copper poisoning in Wilson′s disease using laser ablation inductively coupled plasma mass spectrometry. Ann Transl Med, 2019,7(Suppl 2):S72.
[11] Weiss KH, Askari FK, Czlonkowska A, et al. Bis-choline tetrathiomolybdate in patients with Wilson′s disease: an open-label, multicentre, phase 2 study. Lancet Gastroenterol Hepatol, 2017,2:869-876.
[12] Murillo O, Luqui DM, Gazquez C, et al. Long-term metabolic correction of Wilson′s disease in a murine model by gene therapy. J Hepatol, 2016,64:419-426.
[13] Alam S, Lal BB, Sood V, et al. AARC-ACLF score: best predictor of outcome in children and adolescents with decom-pensated Wilson disease. Hepatol Int, 2019,13:330-338.
[14] Laurencin C, Brunet AS, Dumortier J, et al. Liver Trans-plantation in Wilson′s Disease with Neurological Impairment: Evaluation in 4 Patients. Eur Neurol, 2017,77:5-15. .
[15] Pfeiffenberger J, Beinhardt S, Gotthardt DN, et al. Pregnancy in Wilson′s disease: Management and outcome. Hepatology, 2018,67:1261-1269. |
